Generic Name and Formulations:
Albendazole 200mg; tabs.
Indications for ALBENZA:
Parenchymal neurocysticercosis from active lesions due to Taenia solium (pork tapeworm). Cystic hydatid disease of the liver, lung, and peritoneum due to Echinococcus granulosus (dog tapeworm).
Adults and Children:
See literature. Take with meals. Neurocysticercosis: Give for 8–30 days. Hydatid: Give for 28-day cycle followed by a 14-day free interval, for a total of 3 cycles. <6yrs: not recommended. ≥6yrs (<60kg): 15mg/kg per day in 2 divided doses; max 800mg/day. ≥6yrs (≥60kg): 400mg twice a day.
Examine for retinal lesions first. Monitor blood and hepatic function at beginning of each 28-day cycle and at least every 2 weeks; discontinue if significant increased liver enzymes or if decreases in blood counts occur. Neurocysticercosis: may need corticosteroids during the 1st week of therapy and anticonvulsants. Pregnancy (Cat.C): obtain (–) pregnancy test first. Avoid pregnancy during or for at least 1 month after stopping; discontinue if pregnancy occurs. Nursing mothers.
Potentiated by dexamethasone, praziquantel, cimetidine. Monitor theophylline.
Abnormal liver function test, abdominal pain, GI upset, headache, dizziness, increased intracranial pressure, meningeal signs, reversible alopecia, fever; rarely: leukopenia, rash, acute renal failure, hematological reactions.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|